Effects	O
of	O
dietary	O
folate	O
on	O
ulcerative	B-Pathological_formation
colitis	O
-	O
associated	O
colorectal	B-Multi-tissue_structure
carcinogenesis	O
in	O
the	O
interleukin	O
2	O
-	O
and	O
beta	O
(	O
2	O
)	O
-	O
microglobulin	O
-	O
deficient	O
mice	O
.	O

Folate	O
supplementation	O
may	O
reduce	O
the	O
risk	O
of	O
colorectal	B-Pathological_formation
dysplasia	I-Pathological_formation
and	O
cancer	B-Cancer
in	O
subjects	O
with	O
chronic	O
ulcerative	B-Pathological_formation
colitis	O
(	O
UC	O
)	O
.	O

The	O
interleukin	O
(	O
IL	O
)	O
2	O
-	O
and	O
beta	O
(	O
2	O
)	O
-	O
microglobulin	O
(	O
beta	O
(	O
2	O
)	O
m	O
)	O
-	O
deficient	O
(	O
IL	O
-	O
2	O
(	O
null	O
)	O
x	O
beta	O
(	O
2	O
)	O
m	O
(	O
null	O
)	O
)	O
mice	O
spontaneously	O
develop	O
colon	B-Cancer
cancer	I-Cancer
in	O
the	O
setting	O
of	O
chronic	O
UC	O
.	O

This	O
study	O
investigated	O
the	O
effects	O
of	O
dietary	O
folate	O
on	O
the	O
development	O
of	O
UC	O
-	O
associated	O
colon	B-Cancer
cancer	I-Cancer
in	O
the	O
IL	O
-	O
2	O
(	O
null	O
)	O
x	O
beta	O
(	O
2	O
)	O
m	O
(	O
null	O
)	O
mice	O
.	O

Weaning	O
IL	O
-	O
2	O
(	O
null	O
)	O
x	O
beta	O
(	O
2	O
)	O
m	O
(	O
null	O
)	O
mice	O
were	O
randomized	O
to	O
receive	O
0	O
(	O
deficient	O
;	O
n	O
=	O
40	O
)	O
,	O
2	O
(	O
basal	O
requirement	O
;	O
control	O
;	O
n	O
=	O
46	O
)	O
,	O
or	O
8	O
(	O
supplemented	O
;	O
n	O
=	O
36	O
)	O
mg	O
folate	O
/	O
kg	O
diet	O
for	O
32	O
weeks	O
.	O

At	O
necropsy	O
,	O
all	O
macroscopic	O
colonic	B-Cancer
tumors	I-Cancer
were	O
identified	O
and	O
histologically	O
classified	O
as	O
dysplasia	B-Pathological_formation
or	O
adenocarcinoma	B-Cancer
.	O

The	O
incidence	O
of	O
high	B-Pathological_formation
-	I-Pathological_formation
grade	I-Pathological_formation
lesions	I-Pathological_formation
(	O
high	B-Pathological_formation
-	I-Pathological_formation
grade	I-Pathological_formation
dysplasia	I-Pathological_formation
/	O
carcinoma	B-Cancer
in	I-Cancer
situ	I-Cancer
and	O
invasive	B-Cancer
adenocarcinoma	I-Cancer
)	O
in	O
the	O
folate	O
-	O
supplemented	O
group	O
was	O
46	O
%	O
lower	O
than	O
that	O
in	O
the	O
control	O
group	O
(	O
35	O
.	O
3	O
%	O
versus	O
65	O
.	O
1	O
%	O
,	O
P	O
=	O
0	O
.	O
009	O
)	O
.	O

The	O
incidence	O
of	O
high	B-Pathological_formation
-	I-Pathological_formation
grade	I-Pathological_formation
lesions	I-Pathological_formation
in	O
the	O
folate	O
-	O
deficient	O
group	O
was	O
also	O
49	O
%	O
lower	O
than	O
that	O
in	O
the	O
control	O
group	O
(	O
33	O
.	O
3	O
%	O
versus	O
65	O
.	O
1	O
%	O
,	O
P	O
=	O
0	O
.	O
007	O
)	O
.	O

The	O
higher	O
mortality	O
rate	O
in	O
the	O
folate	O
-	O
deficient	O
group	O
compared	O
with	O
the	O
other	O
two	O
groups	O
(	O
25	O
%	O
versus	O
6	O
.	O
5	O
%	O
and	O
5	O
.	O
6	O
%	O
,	O
P	O
<	O
0	O
.	O
02	O
)	O
partially	O
accounted	O
for	O
the	O
low	O
incidence	O
of	O
high	B-Pathological_formation
-	I-Pathological_formation
grade	I-Pathological_formation
lesions	I-Pathological_formation
in	O
this	O
group	O
.	O

These	O
data	O
indicate	O
that	O
dietary	O
folate	O
supplementation	O
at	O
4x	O
the	O
basal	O
dietary	O
requirement	O
significantly	O
suppresses	O
UC	O
-	O
associated	O
colorectal	B-Multi-tissue_structure
carcinogenesis	O
in	O
the	O
IL	O
-	O
2	O
(	O
null	O
)	O
x	O
beta	O
(	O
2	O
)	O
m	O
(	O
null	O
)	O
mice	O
.	O

These	O
data	O
also	O
suggest	O
that	O
folate	O
deficiency	O
may	O
inhibit	O
colorectal	B-Multi-tissue_structure
carcinogenesis	O
in	O
chronic	O
UC	O
.	O

However	O
,	O
the	O
high	O
mortality	O
observed	O
in	O
the	O
folate	O
-	O
deficient	O
group	O
precludes	O
a	O
definitive	O
conclusion	O
concerning	O
the	O
effect	O
of	O
folate	O
deficiency	O
on	O
UC	O
-	O
associated	O
colorectal	B-Multi-tissue_structure
carcinogenesis	O
in	O
this	O
model	O
.	O

